CA Stock MarketDetailed Quotes

Quest PharmaTech Inc (QPT)

Watchlist
  • 0.040
  • +0.005+14.29%
15min DelayMarket Closed Jan 15 16:00 ET
6.77MMarket Cap-40.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quest PharmaTech Inc (QPT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Oct 31, 2025
(Q2)Jul 31, 2025
(Q1)Apr 30, 2025
(FY)Jan 31, 2025
(Q4)Jan 31, 2025
(Q3)Oct 31, 2024
(Q2)Jul 31, 2024
(Q1)Apr 30, 2024
(FY)Jan 31, 2024
(Q4)Jan 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.93%240.58K
-12.84%156.58K
1.61%117.03K
-37.89%817.29K
-21.38%277.16K
56.69%245.31K
-70.50%179.65K
-41.75%115.17K
57.73%1.32M
62.36%352.52K
Selling and administrative expenses
26.76%180.7K
-22.79%92.08K
19.55%60.53K
-36.85%488.1K
-40.53%175.66K
50.48%142.56K
-53.95%119.26K
-59.12%50.63K
55.22%772.96K
1,555.93%295.38K
-General and administrative expense
26.76%180.7K
-22.79%92.08K
19.55%60.53K
-36.85%488.1K
-40.53%175.66K
50.48%142.56K
-53.95%119.26K
-59.12%50.63K
55.22%772.96K
1,555.93%295.38K
Research and development costs
-41.73%59.87K
6.81%64.51K
-12.46%56.5K
-39.36%329.18K
77.64%101.5K
66.19%102.75K
-82.75%60.39K
-12.63%64.54K
61.46%542.86K
-75.93%57.14K
Operating profit
1.93%-240.58K
12.84%-156.58K
-1.61%-117.03K
37.89%-817.29K
21.38%-277.16K
-56.69%-245.31K
70.50%-179.65K
41.75%-115.17K
-57.73%-1.32M
-62.36%-352.52K
Net non-operating interest income (expenses)
50.76%-5.11K
16.20%-5.11K
16.28%-5.07K
-9.50%-22.64K
97.78%-121
-86.06%-10.37K
-15.25%-6.1K
-39.07%-6.06K
1.53%-20.68K
-2.23%-5.46K
Non-operating interest expense
-50.76%5.11K
-16.20%5.11K
-16.28%5.07K
9.50%22.64K
-97.78%121
86.06%10.37K
15.25%6.1K
39.07%6.06K
-1.53%20.68K
2.23%5.46K
Other net income (expenses)
355.98%1.32M
-101.60%-14.48K
210.42%817.18K
42.84%-961.13K
12.59%-1.42M
148.57%290.41K
104.77%905.31K
-877.79%-740.1K
97.37%-1.68M
97.39%-1.62M
Gain on sale of security
-75.00%1
-100.66%-2.62K
1,253.19%686.38K
65.66%-458.79K
65.77%-457.17K
-91.30%4
26,874.40%396.25K
-3,161.37%-59.52K
97.82%-1.34M
97.74%-1.34M
Other non-operating income (expenses)
0.00%75K
0.00%75K
0.00%75K
75.73%300K
1,600.00%75K
--75K
-47.11%75K
121.24%75K
-62.06%170.72K
-101.52%-5K
Income before tax
3,005.53%1.08M
-124.48%-176.17K
180.70%695.08K
40.32%-1.8M
14.39%-1.69M
104.57%34.73K
517.86%719.56K
-705.53%-861.33K
95.35%-3.02M
96.82%-1.98M
Income tax
0
0
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
3,005.53%1.08M
-124.48%-176.17K
180.70%695.08K
40.32%-1.8M
14.39%-1.69M
104.57%34.73K
517.86%719.56K
-705.53%-861.33K
95.35%-3.02M
96.82%-1.98M
Net income continuous operations
3,005.53%1.08M
-124.48%-176.17K
180.70%695.08K
40.32%-1.8M
14.39%-1.69M
104.57%34.73K
517.86%719.56K
-705.53%-861.33K
95.35%-3.02M
96.82%-1.98M
Noncontrolling interests
Net income attributable to the company
3,005.53%1.08M
-124.48%-176.17K
180.70%695.08K
40.32%-1.8M
14.39%-1.69M
104.57%34.73K
517.86%719.56K
-705.53%-861.33K
95.35%-3.02M
96.82%-1.98M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
3,005.53%1.08M
-124.48%-176.17K
180.70%695.08K
40.32%-1.8M
14.39%-1.69M
104.57%34.73K
517.86%719.56K
-705.53%-861.33K
95.35%-3.02M
96.82%-1.98M
Diluted earnings per share
3,100.00%0.0064
-123.26%-0.001
180.39%0.0041
38.89%-0.011
12.61%-0.0104
104.44%0.0002
530.00%0.0043
-750.00%-0.0051
95.31%-0.018
96.73%-0.0119
Basic earnings per share
3,100.00%0.0064
-123.26%-0.001
180.39%0.0041
38.89%-0.011
12.61%-0.0104
104.44%0.0002
530.00%0.0043
-750.00%-0.0051
95.31%-0.018
96.73%-0.0119
Dividend per share
0
0
0
0
0
0
0
0
0
0
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Oct 31, 2025(Q2)Jul 31, 2025(Q1)Apr 30, 2025(FY)Jan 31, 2025(Q4)Jan 31, 2025(Q3)Oct 31, 2024(Q2)Jul 31, 2024(Q1)Apr 30, 2024(FY)Jan 31, 2024(Q4)Jan 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.93%240.58K-12.84%156.58K1.61%117.03K-37.89%817.29K-21.38%277.16K56.69%245.31K-70.50%179.65K-41.75%115.17K57.73%1.32M62.36%352.52K
Selling and administrative expenses 26.76%180.7K-22.79%92.08K19.55%60.53K-36.85%488.1K-40.53%175.66K50.48%142.56K-53.95%119.26K-59.12%50.63K55.22%772.96K1,555.93%295.38K
-General and administrative expense 26.76%180.7K-22.79%92.08K19.55%60.53K-36.85%488.1K-40.53%175.66K50.48%142.56K-53.95%119.26K-59.12%50.63K55.22%772.96K1,555.93%295.38K
Research and development costs -41.73%59.87K6.81%64.51K-12.46%56.5K-39.36%329.18K77.64%101.5K66.19%102.75K-82.75%60.39K-12.63%64.54K61.46%542.86K-75.93%57.14K
Operating profit 1.93%-240.58K12.84%-156.58K-1.61%-117.03K37.89%-817.29K21.38%-277.16K-56.69%-245.31K70.50%-179.65K41.75%-115.17K-57.73%-1.32M-62.36%-352.52K
Net non-operating interest income (expenses) 50.76%-5.11K16.20%-5.11K16.28%-5.07K-9.50%-22.64K97.78%-121-86.06%-10.37K-15.25%-6.1K-39.07%-6.06K1.53%-20.68K-2.23%-5.46K
Non-operating interest expense -50.76%5.11K-16.20%5.11K-16.28%5.07K9.50%22.64K-97.78%12186.06%10.37K15.25%6.1K39.07%6.06K-1.53%20.68K2.23%5.46K
Other net income (expenses) 355.98%1.32M-101.60%-14.48K210.42%817.18K42.84%-961.13K12.59%-1.42M148.57%290.41K104.77%905.31K-877.79%-740.1K97.37%-1.68M97.39%-1.62M
Gain on sale of security -75.00%1-100.66%-2.62K1,253.19%686.38K65.66%-458.79K65.77%-457.17K-91.30%426,874.40%396.25K-3,161.37%-59.52K97.82%-1.34M97.74%-1.34M
Other non-operating income (expenses) 0.00%75K0.00%75K0.00%75K75.73%300K1,600.00%75K--75K-47.11%75K121.24%75K-62.06%170.72K-101.52%-5K
Income before tax 3,005.53%1.08M-124.48%-176.17K180.70%695.08K40.32%-1.8M14.39%-1.69M104.57%34.73K517.86%719.56K-705.53%-861.33K95.35%-3.02M96.82%-1.98M
Income tax 0000000000
Earnings from equity interest net of tax
Net income 3,005.53%1.08M-124.48%-176.17K180.70%695.08K40.32%-1.8M14.39%-1.69M104.57%34.73K517.86%719.56K-705.53%-861.33K95.35%-3.02M96.82%-1.98M
Net income continuous operations 3,005.53%1.08M-124.48%-176.17K180.70%695.08K40.32%-1.8M14.39%-1.69M104.57%34.73K517.86%719.56K-705.53%-861.33K95.35%-3.02M96.82%-1.98M
Noncontrolling interests
Net income attributable to the company 3,005.53%1.08M-124.48%-176.17K180.70%695.08K40.32%-1.8M14.39%-1.69M104.57%34.73K517.86%719.56K-705.53%-861.33K95.35%-3.02M96.82%-1.98M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 3,005.53%1.08M-124.48%-176.17K180.70%695.08K40.32%-1.8M14.39%-1.69M104.57%34.73K517.86%719.56K-705.53%-861.33K95.35%-3.02M96.82%-1.98M
Diluted earnings per share 3,100.00%0.0064-123.26%-0.001180.39%0.004138.89%-0.01112.61%-0.0104104.44%0.0002530.00%0.0043-750.00%-0.005195.31%-0.01896.73%-0.0119
Basic earnings per share 3,100.00%0.0064-123.26%-0.001180.39%0.004138.89%-0.01112.61%-0.0104104.44%0.0002530.00%0.0043-750.00%-0.005195.31%-0.01896.73%-0.0119
Dividend per share 0000000000
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.16%
Sample Name
Sample Code
 +13.99%
Sample Name
Sample Code
 +13.43%
4
BIDU-SW
09888
+6.11%
5
JD HEALTH
06618
+4.78%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -